drospirenone/ ethinyloestradiol-gh tablets 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack
lupin australia pty limited - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - for use as an oral contraceptive
drospirenone/ ethinyloestradiol-lupin tablets 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister
lupin australia pty limited - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - for use as an oral contraceptive
yana drospirenone 3 mg and ethinylestradiol 20 microgram film coated tablet blister pack
arrotex pharmaceuticals pty ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; povidone; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - this medicine is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception. ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg /ethinylestradiol 20 ?g for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg /ethinylestradiol 20 ?g has not been evaluated for treatment of pms (premenstrual syndrome), see section 5.1 pharmacodynamic properties - clinical trials.
yaz drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack
bayer australia ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, uncoated - excipient ingredients: magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; purified talc; microcrystalline cellulose - yaz is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception - treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms (premenstrual syndrome), see clinical trials.
yaz drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack
bayer australia ltd - drospirenone,ethinylestradiol -
isabelle tablets 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack
lupin australia pty limited - ethinylestradiol, quantity: 30 microgram; drospirenone, quantity: 3 mg - tablet - excipient ingredients: maize starch; magnesium stearate; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; macrogol 400 - for use as an oral contraceptive
bharya 3 mg - 0.02 mg tabl.
viatris gx bv-srl - drospirenone 3 mg (light yellow tablet); ethinylestradiol 0,02 mg (light yellow tablet); placebo (green tablet) - tablet - 3 mg - 0,02 mg - drospirenone 3 mg; ethinylestradiol 0.02 mg; placebo - drospirenone and ethinylestradiol
ellanite 0.03mg/3mg tablets
kent pharma (uk) ltd - drospirenone; ethinylestradiol - oral tablet - 3mg ; 30microgram
yelena drospirenone 3 mg and ethinylestradiol 30 microgram film-coated tablet blister pack
arrotex pharmaceuticals pty ltd - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: povidone; magnesium stearate; lactose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - indicated for use as an oral contraceptive
drospibel continu 0.03 mg - 3 mg film-coat. tabl.
effik benelux sa-nv - drospirenone 3 mg; ethinylestradiol 0,03 mg - film-coated tablet - 0,03 mg - 3 mg - drospirenone 3 mg; ethinylestradiol 0.03 mg - drospirenone and ethinylestradiol